Dive Into Our Science
Explore insitro’s latest publications and presentations to learn more about the science behind our pipeline of insights.
From Insights
to Patient Value
The insitro platform powers the discovery of new medicines for a range of therapeutic areas. We focus on diseases where machine learning can make a transformative difference, by interrogating rich sources of clinical data or where we can construct tractable but high-content cell models for discovery and validation. Most critically, we prioritize our efforts toward diseases with significant unmet needs, maximizing our potential impact on patient health.
insitro is uncovering novel targets, leveraging human and cellular data, to increase the therapeutic probability of success. These insights provide the starting point for discovering new molecules, which we build with either our AI-enabled drug discovery platforms or with partners that extend our impact.
Metabolism
insitro is engaged in advanced research to address metabolic pathologies, specifically focusing on metabolic-associated steatotic liver disease (MASLD) and obesity, in conjunction with their correlated disorders.
MASLD
Obesity
Neuroscience
We have ongoing work in a number of neurodegenerative conditions that impact both larger and smaller patient populations, including ALS.
ALS
Neurodegeneration
Partner with insitro
Interested in partnering with insitro? Contact bd@insitro.com to explore strategic collaboration opportunities.